Vigil Neuroscience, Inc. (VIGL)
NASDAQ: VIGL · Real-Time Price · USD
7.86
0.00 (0.00%)
Jun 12, 2025, 1:44 PM - Market open

Vigil Neuroscience Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-86.73-84.26-82.64-68.31-43.28-57.09
Depreciation & Amortization
0.460.450.40.080.03-
Asset Writedown & Restructuring Costs
-----41.85
Loss (Gain) From Sale of Investments
-1.36-1.56-1.49---
Stock-Based Compensation
10.4510.128.95.482.090.52
Other Operating Activities
1.431.411.360.931.182.66
Change in Accounts Payable
1.080.020.01-2.482.352.21
Change in Unearned Revenue
20.0120.01----
Change in Other Net Operating Assets
1.432.593.09-0.85-1.71-0.51
Operating Cash Flow
-53.24-51.22-70.36-65.15-39.35-10.36
Capital Expenditures
-0.29-0.01-0.67-0.92-0.2-
Sale (Purchase) of Intangibles
------1
Investment in Securities
15.818.77-64.46---
Investing Cash Flow
15.528.76-65.14-0.92-0.2-1
Total Debt Issued
-----10
Long-Term Debt Repaid
---0.02-0.04-0.04-
Net Debt Issued (Repaid)
---0.02-0.04-0.0410
Issuance of Common Stock
17.769.680.91140.620.040
Other Financing Activities
---20.68-1.89-
Financing Cash Flow
37.5729.490.89161.26107.7559.66
Net Cash Flow
-0.14-12.97-134.6195.1968.248.3
Free Cash Flow
-53.53-51.23-71.04-66.07-39.55-10.36
Free Cash Flow Per Share
-1.27-1.26-1.83-2.08-25.82-7.68
Levered Free Cash Flow
-23.2-21.95-40.06-41.43-22.5-
Unlevered Free Cash Flow
-23.2-21.95-40.06-41.43-22.5-
Change in Net Working Capital
-23.52-23.53-6.853.01-2.1-
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q